Stay updated on Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes are indicated.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding/operating status notice was removed; these site maintenance changes do not affect the study information, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check38 days agoChange DetectedUpdated study plan sections add NIH-required analyses and core outcome definitions (overall survival by race/ethnicity/sex, time to progression, progression-free survival) and the follow-up schedule. A funding lapse notice and revised dates (2026-01-08, 2026-01-28) are now displayed.SummaryDifference0.8%

- Check45 days agoChange DetectedGlossary toggle added for user assistance, and the page now includes QC-related update fields (Last Update Submitted that Met QC Criteria, Last Update Posted) with the site revision updated to v3.4.0 (from v3.3.4).SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check81 days agoChange DetectedLocations section updated to a consolidated list of sites (California, Colorado, Connecticut, Florida, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Mississippi, Missouri, New Jersey, New York, Ohio, Oregon, Pennsylvania, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, Victoria, Alberta, Ontario, Quebec, Korea) with previous per-location entries removed; a new Revision: v3.3.3 tag is displayed.SummaryDifference2%

Stay in the know with updates to Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.